TMRW Life Sciences

TMRW Life Sciences

Provides an integrated platform for automated, software-guided cryospecimen management. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
*

$25.0m

Series B

$52.5m

Series C

$52.5m

Debt
*

N/A

Late VC
*

$28.0m

Valuation: $263m

Series D
Total Funding€107m

Recent News about TMRW Life Sciences

Edit
More about TMRW Life Sciences
Edit

TMRW is a pioneering startup that is revolutionizing the field of assisted reproductive technology. The company has developed the world's first and only automated platform for the safe management and storage of frozen eggs and embryos. This innovative technology is designed to serve fertility clinics and their patients, a market that is growing rapidly due to advances in reproductive technology.

TMRW's business model is centered around providing a much-needed solution to fertility clinics. These clinics are facing increasing demand for egg and embryo storage, and TMRW's platform helps them upgrade, optimize, and safely scale their operations. The platform also offers patients the highest levels of safety, security, and transparency for their precious cells.

The company's platform is FDA-cleared and uses next-generation technology to provide a new standard of care. It includes features such as digital identification and tracking, which provide unprecedented visibility and transparency. The platform's automated technology reduces manual steps and helps eliminate 93% of the potential points of failure. It also includes a 24/7 cloud-based monitoring system for peace of mind.

TMRW generates revenue by selling its platform to fertility clinics. The company's technology has been recognized as a significant advancement in IVF and is trusted by top fertility clinics.

Keywords: TMRW, fertility clinics, assisted reproductive technology, automated platform, egg and embryo storage, safety, security, transparency, FDA-cleared, cloud-based monitoring.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.